Factors that influence current tuberculosis epidemiology

European Spine Journal

Volumn 22, Issue SUPPL.4, 2013, Pages

  Millet, Juan Pablo ^a,b,c   Moreno, Antonio ^a,b,c   Fina, Laia ^a,b,c   Baño, Lucía Del ^a,b,c   Orcau, Angels ^a,b,c   De Olalla, Patricia García ^a,b,c   Caylà, Joan A ^a,b,c  

^a AGÈNCIA DE SALUT PÚBLICA DE BARCELONA   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c Tuberculosis Investigation Unit of Barcelona (UiTB)   (Spain)

Author keywords

Epidemiology; Pott disease; Risk factors; Spine; Tuberculosis

Indexed keywords

ANTIRETROVIRUS AGENT; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ALCOHOL ABUSE; ANTIBIOTIC RESISTANCE; CITY; COMMUNITY; CROWDING (AREA); DEVELOPED COUNTRY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SURVEILLANCE; DRUG ABUSE; ECONOMIC ASPECT; EUROPE; HEALTH PROGRAM; HISTORY OF MEDICINE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMIGRATION; INCIDENCE; INFLAMMATORY DISEASE; LOWEST INCOME GROUP; MALNUTRITION; MIGRATION; MORTALITY; MULTIDRUG RESISTANCE; OSTEOARTHROPATHY; PANDEMIC; PATHOGENESIS; POLITICS; POVERTY; PREVENTION AND CONTROL; PRIORITY JOURNAL; PUBLIC HEALTH PROBLEM; REVIEW; RISK FACTOR; SMOKING; SOCIAL ASPECT; SURVIVAL; TOBACCO; TUBERCULOSIS; TUBERCULOUS SPONDYLITIS; WORLD HEALTH ORGANIZATION;

EID: 84888109677     PISSN: 09406719     EISSN: 14320932     Source Type: Journal    
DOI: 10.1007/s00586-012-2334-8     Document Type: Review

References (71)

1. World Health Organization (2011) Global Tuberculosis Control. http://www.who.int/tb/publications/global-report/en/.
2. Keshavjee S, Harrington M, Gonsalves G, Chesire L, Farmer PE (2011) Time for zero deaths from tuberculosis. Lancet 378(9801): 1449-1450.
3. Shaw JB, Wynn-Williams N (1954) Infectivity of pulmonary tuberculosis in relation to sputum status. Am Rev Tuberc 69(5):724-732.
4. Grzybowski S, Barnett GD, Styblo K (1975) Contacts of cases of active pulmonary tuberculosis. Bull Int Union Tuberc 50(1):90- 106.
5. van Geuns HA, Meijer J, Styblo K (1975) Results of contact examination in Rotterdam, 1967-1969. Bull Int Union Tuberc 50(1):107-121.
6. Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC (1999) Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 282(7):677-686.
7. Advisory Council for the Elimination of Tuberculosis (ACET) (1999) Tuberculosis elimination revisited: obstacles, opportunities, and a renewed commitment. MMWR Recomm Rep 48(9):1-13.
8. Institute of Medicine (US) Committee on the Elimination of Tuberculosis in the United States (2000) Endling neglect: The elimination of tuberculosis in the United States, National Academy Press, Washington, DC.
9. Orcau A, Cayla JA, Martinez JA (2011) Present epidemiology of tuberculosis, Prevention and control programs. Enferm Infecc Microbiol Clin Suppl 1:2-7.
10. Houshian S, Poulsen S, Riegels-Nielsen P (2000) Bone and joint tuberculosis in Denmark: increase due to immigration. Acta Orthop Scand 71(3):312-315.
11. Forssbohm M, Zwahlen M, Loddenkemper R, Rieder HL (2008) Demographic characteristics of patients with extrapulmonary tuberculosis in Germany. Eur Respir J 31(1):99-105.
12. Talbot JC, Bismil Q, Saralaya D, Newton DA, Frizzel RM, Shaw DL (2007) Musculoskeletal tuberculosis in Bradford-a 6-year review. Ann R Coll Surg Engl 89(4):405-409.
13. Garcia-Lechuz JM, Julve R, Alcala L, Ruiz-Serrano MJ, Munoz P (2002) Espondilodiscitis tuberculosa o enfermedad de Pott: experiencia en un hospital general. Enferm Infecc Microbiol Clin 20(1):5-9.
14. United Nations, Department of Economic and Social Affairs, Population Division (2009) Trends in International Migrant Stock: The 2008 (United Nations database, POP/DB/MIG/Stock/Rev.2008).
15. Rieder HL, Zellweger JP, Raviglione MC, Keizer ST, Migliori GB (1994) Tuberculosis control in Europe and international migration. Eur Respir J 7:1545-1553.
16. Tuberculosis Surveillance Report in Europe 2009. European Centre for Disease Prevention and Control (ECDC) and WHO regional office for Europe.
17. Marin M, Moreno R, Gil M, Bueso MJ, Romeu MA, Gonzalez F (2010) Impacto de la inmigracion desde Rumania en la tuberculosis de un area mediterranea. Enf Emerg 12:115-120.
18. Cayla JA, Orcau A Control of tuberculosis in large cities in developed countries: An organisational problem. BMC Medicine (in press).
19. Bothamley GH, Kruijshaar ME, Kunst H, Woltmann G, Cotton M, Saralaya D, Woodhead MA, Watson JP, Chapman ALN. Tuberculosis in UK cities: workload and effectiveness of TB control programmes. BMC Public Health (in press).
20. Tuberculosis in the UK. Report on tuberculosis surveillance in the UK 2010 Health Protection Agency.
21. Gatell JM, Zulaica D, Del Romero J (2010) Como promover y facilitar el diagnostico precoz de la infeccion por el VIH-1. Enf Emerg 12:121-124.
22. Selwyn PA, Hartel D, Lewis VA, Schoenbaum EE, Vermund SH, Klein RS et al (1989) A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med 320:545-550.
23. Getahun H, Gunneberg C, Granich R, Nunn P (2010) HIV infection-associated tuberculosis: The epidemiology and the response. Clin Infect Dis 50(Suppl 3):S201-S207.
24. Decker CF, Masur H (1994) Current status of prophylaxis for opportunistic infections in HIV-infected patients. AIDS 8:11-20.
25. Fischl MA, Richman DD, Grieco MH, Gottlieb MS, Volberding PA, Laskin OL, Leedom JM, Groopman JE, Mildvan D, Schooley RT et al (1987) The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N Engl J Med 317:185- 191.
26. Leroy V, Salmi LR, Dupon M, Sentilhes A, Texier-Maugein J, Dequae L, Dabis F, Salamon R (1997) A cohort study in Bordeaux, France, 1988-1994. The Groupe d'Epidemiologie Clinique du Sida en Aquitaine (GECSA). Am J Epidemiol 15:293-300.
27. Pablos-Mendez A, Sterling TR, Frieden TR (1996) The relationship between delayed or incomplete treatment and all-cause mortality in patients with tuberculosis. JAMA 276:1223-1228.
28. Garcia de Olalla P, Martinez-Gonzalez MA, Cayla JA, Jansa JM, Iglesias B, Guerrero R, Marco A, Gatell JM, Ocana I, Barcelona AIDS-TB Study Group (2002) Influence of highly active antiretroviral therapy (HAART) on the natural history of extra-pulmonary tuberculosis in HIV patients. Int J Tuberc Lung Dis 6:1051-1057.
29. Leonard MK, Larsen N, Drechsler H et al (2002) Increased survival of persons with tuberculosis and human immunodeficiency virus infection, 1991-2000. Clin Infect Dis 34:1002-1007.
30. Thseng SH, Shyong-Jiang DD, Hoi HS, Lo HY, Hwang KP (2009) Effect of free treatment and surveillance on HIV-infected persons who have tuberculosis, Taiwan, 1993-2006. Emerg Infect Dis 15:332-334.
31. Hung CC, Chen MY, Hsiao CF, Hsieh SM, Sheng WH, Chang SC (2003) Improved outcomes of HIV-1-infected adults with tuberculosis in the era of highly active antiretroviral therapy. AIDS 17:2615-2622.
32. Selwyn PA, Hartel D, Lewis VA, Schoenbaum EE, Vermund SH, Klein RS et al (1989) A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med 320(9):545-550.
33. Deiss RG, Rodwell TC, Garfein RS (2009) Tuberculosis and illicit drug use: review and update. Clin Infect Dis 48(1):72-82.
34. European Centre for Disease Prevention and Control and European Monitoring Centre for Drugs and Drug Addiction (2011) Prevention and control of infectious diseases among people who inject drugs. Stockholm: ECDC. http://www.ecdc.europa.eu/en/publications/Publications/111012-Guidance-ECDC- EMCDDA.pdf).
35. WHO Report on the global tobacco epidemic (2011). http://whqlibdoc.who. int/publications/2011/9789240687813-eng.pdf.
36. Shafey O, Eriksen M, Ross H, Mackay J (2009) El atlas del tabaco. Sociedad Americana del Cancer 3:18-21.
37. Ministerio de Sanidad. Encuesta Nacional de Salud de Espana (1987-2006).http://msps.es/estadEstudios/estadisticas/encuestaNacional/ encuesta2006.htm.
38. Leung CM, Leung KC, Hon KE, Kong AY (2009) Fighting tobacco smoking-a difficult but not impossible battle. Int J Environ Res Public Health 6:69-83.
39. World Health Organization (2007) The Union against tuberculosis and lung diseases. A WHO/The Union monograph on TB and tobacco control: joining efforts to control two related global epidemics; WHO/HTM/TB/2007.390:21-23.
40. Alcaide J, Altet MN, Plans P, Parron I, Folguera L, Salto E, Dominguez A, Pardell H, Salleras L (1996) Cigarette smoking as a risk factor for tuberculosis in young adults: A case-control study. Tuber Lung Dis 77:112-116.
41. Leng CC, Li T, Lam TH, Yew WW, Law WS, Tam CM, Chan WM, Chan CK, Ho KS, Chang KC (2004) Smoking and tuberculosis among the elderly in Hong Kong. Am J Respir Crit Care Med 170:1027-1033.
42. Lienhardt C, Fielding K, Sillah JS, Bah B, Gustafson P, Warndorff D, Palayew M, Lisse I, Donkor S, Diallo S, Manneh K, Adegbola A, Aaby P, Bah-Sow O, Bennett S, McAdam K (2005) Investigation of the risk factors for tuberculosis: A case-control study in three countries in West Africa. Int J Epidemiol 34:914-923.
43. Lin HH, Ezzati M, Chang HY, Murray M (2009) Association between tobacco smoking and active tuberculosis in Taiwan. Prospective cohort study. Am J Respir Crit Care Med 180:475- 480.
44. Jee SH, Golub JE, Jo J, LlS Park, Ohrr H, Samet JM (2009) Smoking and risk of tuberculosis incidence, mortality, and recurrence in South Korean men and women. Am J Epidemiol 170:1478-1485.
45. Slama K, Chiang CY, Enarson DA, Hassmiller Fanning A, Gupta P, Ray C (2007) Tobacco and tuberculosis: A qualitative systematic review and meta-analysis. Int J Tuberc Lung Dis 11:1049- 1061.
46. Lin HH, Ezzati M, Murray M (2007) Tobacco smoke, indoor air pollution and tuberculosis: A systematic review and meta-analysis. PLoS Med 4(1):e20.
47. Bates MN, Khalakdina A, Pai M, Chang L, Lessa F, Smith KR (2007) Risk of tuberculosis from exposure to tobacco smoke. A systematic review and meta-analysis. Arch Intern Med 167:335- 342.
48. den Boon S, Verver S, Marais BJ, Enarson DA, Lombard CJ, Bateman ED, Irusen E, Jithoo A, Gie RP, Borgdorff MW, Beyers N (2007) Association between passive smoking and infection with Mycobacterium tuberculosis in children. Pediatrics 119(4): 734-739.
49. Leung CC, Lam TH, Ho KS, Yew WW, Tam CM, Chan WM, Law WS, Chan CK, Chang KC, Au KF (2010) Passive smoking and tuberculosis. Arch Intern Med 170(3):287-292.
50. Altet MN, Alcaide J, Plans P, Taberner JL, Salto E, Ll Folguera et al (1996) Passive smoking and risk of pulmonary tuberculosis in children immediately following infection. A case-control study. Tub Lung Dis 77:537-544.
51. Singh M, Mynak ML, Kumar L, Mathew JL, Jindal SK (2005) Prevalence and risk factors for transmission of infection among children in household contact with adults having pulmonary tuberculosis. Arch Dis Child 90(6):624-628.
52. World Health Organization/International Union Against Tuberculosis and Lung Disease (2007) Global project on anti-tuberculosis drug resistance surveillance. Anti-tuberculosis drug resistance in the world: report no. 4. Geneva, Switzerland: WHO. http://www.who.int/tb/publications/2008/drs-report4- 26feb08.pdf.
53. Sharma SK, Mohan A (2006) Multidrug-resistant tuberculosis: A menace that threatens to destabilize tuberculosis control. Chest 130:162-272.
54. World Health Organization (2011) Guidelines for the programmatic management of drug-resistant tuberculosis. http://www.who.int/tb/challenges/mdr/ programmatic-guidelines-for-mdrtb/en/index.html.
55. Towards universal access to diagnosis and treatment of multidrug- resistant and extensively drug-resistant tuberculosis by 2015. 2011. http://www.who.int/tb/features-archive/world-tb-day-mdr-report-2011/en/.
56. La tuberculosi a Barcelona. 2009. http://www.aspb.es/quefem/docs/ Tuberculosi-2009.pdf.
57. Chan ED, Iseman MD (2008) Multidrug-resistant and extensively drug-resistant tuberculosis: A review. Curr Opin Infect Dis 21: 587-595.
58. Ruiz-Manzano J, Blanquer R, Calpe JL, Caminero JA, Cayla J, Dominguez JA, Garcia JM, Vidal R (2008) Diagnostico y tratamiento de la tuberculosis. Normativa SEPAR. Arch Bronconeumol 44:551-566.
59. Sarkar S, Suresh MR (2011) An overview of tuberculosis chemotherapy-a literature review. J Pharm Pharmaceut Sci 14:148-161.
60. Singla R, Caminero JA, Jaswal A, Singla N, Gupta S, Bali RK, Behera D (2011) Linezolid, an effective, safe and cheap drug in MDR-TB treatment failure in India. Eur Respir J (Epub ahead of print).
61. Amaral L, Boeree MJ, Gillespie SH, Udwadia ZF, vanSoonlingen D (2010) Thioridazine cures extensively drug-resistant tuberculosis (XDR-TB) and the need for global trials is now! Int J Antimicrobiol Agents 35:524-526.
62. Our motto. Health News. February 1914;30: Table of contents, Monthly Bulletin: New York State Department of Health.
63. Reichman LB (1997) Defending the Public's health against tuberculosis. JAMA 278:865-867.
64. Reichman LB (1991) The U shaped curve of concern. Am Rev Resp Dis 148:741-742.
65. Frieden TR, Fujiwara PI, Washko RM, Hamburg MA (1995) Tuberculosis in New York city-turning the tide. N Engl J Med 333(4):229-233.
66. New York City, Department of Health and Mental Hygiene (2009) Annual Summary 2008: New York city is stopping TB. New York, NY. http://www.nyc.gov/ html/doh/downloads/pdf/tb/tb-annualsummary08.pdf.
67. Marco A, Cayla JA, Serra M, Pedro R, Sanrama C, Guerrero R, Ribot N (1998) Predictors of adherence to tuberculosis treatment in a supervised therapy programme for prisoners before and after release. Group of Adherence to Tuberculosis Treatment of Prisoners. Eur Respir J 4:967-971.
68. Ospina JE, Orcau A, Millet JP, Cayla JA, Casals M, Rius C, Sanchez F (2009) Effectiveness of community health workers for the control of tuberculosis. Int J Tubec Lung Dis 13(12) suppl 1 (Abstract book. 40th World Conference on Lung Health of the IUATL).
69. Rodrigo T, Cayla JA, Galdos-Tanguis H, Garcia de Olalla P, Brugal MT, Jansa JM (2001) Proposing indicators for evaluation of tuberculosis control programmes in large cities based on the experience of Barcelona. Int J Tuberc Lung Dis 5:432-440.
70. Gillman A, Berggren I, Bergstrom SE, Wahlgren H, Bennet R (2008) Primary tuberculosis infection in 35 children at a Swedish day care center. Pediatr Infect Dis J 27:1078-1082.
71. World Health Organization (2011) Collaborative framework for care and control of tuberculosis and diabetes. http://whqlibdoc.who.int/publications/ 2011/9789241502252-eng.pdf.